CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2025	Mar. 31, 2024
Revenues:
Total revenues	$ 39,603	$ 304
Operating expenses:
Cost of goods sold	1,206	0
Research and development	15,078	29,373
Selling, general and administrative	40,023	27,065
Total operating expenses	56,307	56,438
Loss from operations	(16,704)	(56,134)
Interest income	5,152	4,239
Interest expense	(8,200)	(3,433)
Other income and (expense), net	(83)	(62)
Net loss	$ (19,835)	$ (55,390)
Basic net loss per share (in dollars per share)	$ (0.03)	$ (0.09)
Diluted net loss per share (in dollars per share)	$ (0.03)	$ (0.09)
Shares used in computing basic net loss per share (in shares)	665,905,469	603,493,451
Shares used in computing diluted net loss per share (in shares)	665,905,469	603,493,451
Product revenue, net
Revenues:
Total revenues	$ 39,436	$ 0
Royalties
Revenues:
Total revenues	$ 167	$ 304

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.